Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis
- PMID: 361754
- PMCID: PMC371859
- DOI: 10.1172/JCI109204
Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis
Abstract
A specific inhibitory activity of in vitro proliferative responses of normal human lymphocytes to Candida metabolic antigen was found in the serum of 6 out of 23 children with chronic mucocutaneous candidiasis. In each of the six patients, the presence of an inhibitory activity was associated with Candida-specific cellular defects, characterized by a negative-skin test and a lack of in vitro lymphocyte proliferation. The presence of a circulating inhibitor was detected during relapses of the disease and disappeared under antifungal therapy. This inhibitory effect was not associated with any toxicity on tested lymphocytes. The factor was shown to be nondialysable, thermostable, nonprecipitable with ammonium sulfate and absorbable on anti-Candida antibodies or concanavalin A-coupled agarose columns. Altogether, these results suggest that the inhibitory factor is not an immunoglobulin, but rather a polysaccharidic antigen of Candida albicans. An inhibition of Candida-induced proliferative response of normal human lymphocytes was also obtained by addition of polysacharide antigens or purified mannans from C. albicans to cultures. Candida polysaccharidic antigens appeared, therefore, to be involved in specific depression of cellular functions observed in chronic candidiasis.
Similar articles
-
Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness.Clin Exp Immunol. 1982 Mar;47(3):653-60. Clin Exp Immunol. 1982. PMID: 6211308 Free PMC article.
-
Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.Clin Exp Immunol. 1976 Sep;25(3):497-500. Clin Exp Immunol. 1976. PMID: 786522 Free PMC article.
-
Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.Arch Dermatol. 1979 Feb;115(2):180-4. Arch Dermatol. 1979. PMID: 426525
-
Role of the LFA-1 molecule in cellular interactions required for antibody production in humans.J Immunol. 1986 May 1;136(9):3198-203. J Immunol. 1986. PMID: 3514755
-
Recent advances in cutaneous candidiasis.Int J Dermatol. 1978 Nov;17(9):683-90. doi: 10.1111/ijd.1978.17.9.683. Int J Dermatol. 1978. PMID: 365807 Review. No abstract available.
Cited by
-
Chronic mucocutaneous candidiasis.Eur J Clin Microbiol Infect Dis. 1989 May;8(5):448-56. doi: 10.1007/BF01964059. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2502409 Review.
-
Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes.J Clin Invest. 1983 Jun;71(6):1602-13. doi: 10.1172/jci110916. J Clin Invest. 1983. PMID: 6345586 Free PMC article.
-
Induction of natural killer cell activity by inactivated Candida albicans in mice.Infect Immun. 1985 Oct;50(1):297-303. doi: 10.1128/iai.50.1.297-303.1985. Infect Immun. 1985. PMID: 3899934 Free PMC article.
-
Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness.Clin Exp Immunol. 1982 Mar;47(3):653-60. Clin Exp Immunol. 1982. PMID: 6211308 Free PMC article.
-
Purification and characterization of a mannose-containing disaccharide obtained from human pregnancy urine. A new immunoregulatory saccharide.J Exp Med. 1984 Dec 1;160(6):1672-85. doi: 10.1084/jem.160.6.1672. J Exp Med. 1984. PMID: 6334714 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources